Canadian Natural Resources stock seen 7% undervalued after Q3 returns
Honeywell stock broadens AI building push with 2027 roadmap
Wir sind Helden release Record Store Day vinyl on 27 November
ServiceNow's AI Governance Push Meets a Market Demanding Proof in the Numbers
Altria Group stock weighs higher guidance against smoke-free risks
Siemens Energy's Record Order Book Puts Siemens Gamesa's Next Chapter on the Line
Palantir's 96% Revenue Surge Meets a Stalled Order Book and an Insider Sale
Merck & Co. stock gains as efinopegdutide clears Phase 2b goal
Canadian Pacific Kansas City stock gains freight momentum from grain records
Cemex stock: Record cash flow meets uneven regional execution
Applied Materials stock trades higher before Nov. 12 earnings
Cummins stock weighs record profit against tighter 2026 outlook
CrowdStrike stock slips 2.26% from latest report quote
Caterpillar stock: Lafayette expansion adds jobs and capacity
CVS Health stock weighs higher outlook against medical cost risks
Comfort Systems USA stock: Dividend date puts payout in focus
2G Energy's Order Book Stretches to 2028, but the Balance Sheet Will Have the Final Word
CSX Corporation stock faces 2027 pricing test after CFO remarks
Korn play Hanover on 13 November on EURO TOUR 2026
Ocugen's Q3 Revenue Was $1.95 Million — but the OCU400 Readout Is What Actually Sets the Price
Alibaba stock weighs T-Head IPO plans as approvals remain pending
Arista Networks stock holds AI momentum after record Q3
Gigi Perez joins Out of the Blue in Cancun from 7 January 2027
Banorte stock rises 1.68% since latest report as payout plan holds
Midea stock faces revised earnings outlook after Q3 review
Zijin Mining stock faces fresh political risk at Serbian Bor expansion
Arm Holdings stock gets new data-center signal from server forecasts
Goja released Jingle in my DM’s on 6 November
Advantest stock slips as higher forecast raises execution stakes
Cadence Design Systems stock in focus after OrCAD Xplore launch
Amgen stock: Dazodalibep Phase 3 trial meets key endpoints
Takeda stock gains a new Japan filing for zasocitinib